John Szumowski

9PUBLICATIONS
35CO-AUTHORS
AutoimmunityMedical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Diagnostic radiographyMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 04, 2025
Experience with Linezolid for the Treatment of Rifampin-Susceptible Tuberculosis in San Francisco.

Janice K Louie, Gustavo E Velásquez, Allison Phillips

|Nov 18, 2025
Tuberculosis Infection Screening Recommendations for Targeted Immunotherapies: Comparison of US Prescribing Information, Clinical Resources, and Quality Measures.

Matthew T Murrill, Gustavo E Velásquez, John D Szumowski

|Aug 08, 2025
Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures.

Matthew T Murrill, Gustavo E Velásquez, John D Szumowski

|Oct 05, 2024
Viral Suppression Rates at 48 Weeks in People With HIV Starting Long-Acting Cabotegravir/Rilpivirine With Initial Viremia.

Matthew D Hickey, Nathanael Gistand, Janet Grochowski

|Nov 20, 2023
A Dose-Finding Study to Guide Use of Verapamil as an Adjunctive Therapy in Tuberculosis.

Chandrasekaran Padmapriyadarsini, John D Szumowski, Nabila Akbar

Pageof 2